News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
289–324
Matches
14550
Sources here
20
Companies here
43
Search results Stored financial headlines

Active search

14550 matching headlines

Ticker or company: LSMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Wells Fargo & Company $WFC Shares Sold by Benjamin Edwards Inc.

Benjamin Edwards Inc. reduced its holdings in Wells Fargo & Company by 28.8% in the second quarter, selling 15,899 shares, but still holds 39,388 shares valued at $3.255 million. Meanwhile, other institutional investors like Norges Bank and Amundi increased their stakes in WFC. Analysts …

WFC main company
Sharemaestro market context Trend signal started 52 weeks +14.1% · Next-week setup positive 55.9% WFC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Aurora Investment Counsel Takes Position in ANI Pharmaceuticals, Inc. $ANIP

Aurora Investment Counsel has acquired a new stake of 26,890 shares in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) during the second quarter, valued at approximately $2.23 million. This comes as several other institutional investors have also adjusted their holdings in the specialty pharmaceutical company. ANI Pharmaceuticals …

ANIP main company
Sharemaestro market context Price below Trend Line 52 weeks -15.9% ANIP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Abacus FCF Advisors LLC Purchases New Shares in Archer Daniels Midland Company $ADM

Abacus FCF Advisors LLC has acquired a new position of 103,898 shares in Archer Daniels Midland Company (NYSE:ADM), valued at approximately $7.94 million, making it their 29th largest holding. Several other institutional investors also adjusted their stakes in ADM. The article details ADM's recent …

ADM main company
Sharemaestro market context Trend signal active 52 weeks +30.8% ADM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

How Investors Are Reacting To Aurinia Pharmaceuticals (AUPH) Extended Voclosporin Exclusivity And Share Buyback

Aurinia Pharmaceuticals Inc. recently reported second-quarter 2026 results showing higher revenue and earnings year over year, reiterated its 2026 revenue and net product sales guidance, completed a large share buyback program, and finalized a settlement with Teva Pharmaceuticals that delays U.S. generic voclosporin entry …

AUPH main company
Sharemaestro market context Trend signal active 52 weeks +26.1% · Next-week setup positive 55.9% AUPH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Applied Materials’s Q2 Earnings Call: Our Top 5 Analyst Questions

Applied Materials reported strong Q2 results, exceeding revenue and profitability estimates, driven by robust demand for semiconductor manufacturing equipment. Despite the positive performance and increased guidance for Q3, the market reacted negatively. The article highlights key analyst questions from the earnings call, focusing on …

AMAT main company AMAT main company A1MT34 main company AMAT main company AMAT main company AP2 main company
Sharemaestro market context Trend signal active 52 weeks +267.8% · Next-week setup positive 62.8% AMAT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Precious Metals Stocks Rally Broadly, Wheaton Precious Metals’ Low-Cost Model Stands Out

Precious metals stocks, including Wheaton Precious Metals (WPM), rallied sharply due to a U.S. Treasury Department announcement to expand long-term bond buybacks, which decreased bond yields and increased the appeal of non-yielding assets like gold. Wheaton Precious Metals, a metal streaming company, saw its …

WPM main company
Sharemaestro market context Price above Trend Line 52 weeks +41.1% · Next-week setup positive 60.0% WPM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives Average Rating of "Moderate Buy" from Analysts

Thirteen research firms have given Syndax Pharmaceuticals (NASDAQ:SNDX) an average recommendation of "Moderate Buy," with an average 12-month price target of $41.91. Despite missing Q2 earnings and revenue estimates and insider share sales, institutional investors like BlackRock and Vanguard have increased their stakes. The …

SNDX main company
Sharemaestro market context Price below Trend Line 52 weeks +22.2% SNDX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Phio Pharmaceuticals (PHIO) Chairman Robert Bitterman Buys 10,00

Phio Pharmaceuticals (PHIO) Chairman Robert Bitterman has purchased an additional 10,000 shares of the company, bringing his total holdings to 431,421 shares. This transaction at $1.06 per share reflects a strong insider sentiment, with 6 insider buys and 0 insider sells over the past …

PHIO main company
Sharemaestro market context Price below Trend Line 52 weeks -47.8% · Next-week setup negative 40.9% PHIO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Intercontinental Hotels Group (NYSE:IHG) Stock Price Passes Above Two Hundred Day Moving Average - Here's What Happened

Intercontinental Hotels Group (NYSE:IHG) shares have surpassed their 200-day moving average, trading at $161.5050 after reaching a high of $163.00. The stock maintains a "Moderate Buy" consensus rating with an average price target of $174.50, despite mixed analyst views including a recent downgrade to …

IHG main company
Sharemaestro market context Trend signal active 52 weeks +31.7% · Next-week setup positive 55.1% IHG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Huntington Ingalls Industries Inc. stock underperforms Thursday when compared to competitors

Shares of Huntington Ingalls Industries Inc. (HII) fell by 3.32% on Thursday, closing at $301.40. This decline occurred during a broader market downturn, with the S&P 500 Index and Dow Jones Industrial Average also experiencing losses. This marks the fourth consecutive day of losses …

HII main company
Sharemaestro market context Price below Trend Line 52 weeks +23.5% · Next-week setup positive 57.1% HII stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Applied Materials Delivered a Record Quarter. The Stock Fell Anyway

Applied Materials (AMAT) reported a record fiscal third quarter with revenue up 25% year-over-year and EPS up 41%, exceeding analyst expectations. Despite strong performance and an optimistic outlook driven by AI demand, the stock fell over 3% after-hours, likely due to its "priced for …

AMAT main company AMAT main company A1MT34 main company AMAT main company AMAT main company AP2 main company
Sharemaestro market context Trend signal active 52 weeks +267.8% · Next-week setup positive 62.8% AMAT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Why Regeneron (REGN) Is Up 5.4% After FDA Approves Pasatru For Ultra-Rare FOP Therapy

In August 2026, Regeneron Pharmaceuticals announced that the US FDA approved Pasatru (garetosmab-grts) to reduce new heterotopic ossification lesions and flare-ups in adults with fibrodysplasia ossificans progressiva, based on positive Phase 3 OPTIMA trial results. This approval adds a rare-disease monoclonal antibody to Regeneron's …

REGN main company REGN34 main company REGN main company RGO main company REGN main company
Sharemaestro market context Price above Trend Line 52 weeks +24.3% · Next-week setup negative 36.4% REGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Air Products (APD) Stock Looks Fully Priced Despite A 14% Fair Value Gap

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Air Products and Chemicals has delivered a 27.8% total return over the past five …

APD main company AP3 main company APCD main company
Sharemaestro market context Trend signal active 52 weeks +5.3% APD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Regeneron (REGN) Stock Looks Undervalued On Expanded Cancer Collaboration News

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Regeneron Pharmaceuticals stock has delivered a 43.0% return over the past year, yet the …

REGN main company REGN34 main company REGN main company RGO main company REGN main company
Sharemaestro market context Price above Trend Line 52 weeks +24.3% · Next-week setup negative 36.4% REGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Mirum Pharmaceuticals(MIRM.US) Officer Sells US$4 Million in Common Stock

A Mirum Pharmaceuticals officer recently sold common stock valued at approximately $4 million. This transaction indicates a significant insider sale at the company.

MIRM main company
Sharemaestro market context Trend signal active 52 weeks +40.7% · Next-week setup positive 56.4% MIRM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context